Antibe Therapeutics Inc (ATBPF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-2020 | 12-2019 | 09-2019 | 06-2019 | 03-2019 | |
| Sales | 1,747 | 1,978 | 1,718 | 2,066 | 1,826 |
| Cost of Goods | 1,033 | 1,255 | 1,006 | 1,291 | 1,299 |
| Gross Profit | 713 | 723 | 712 | 775 | 527 |
| Operating Expenses | 5,761 | 4,139 | 4,390 | 3,441 | 4,067 |
| Operating Income | -5,015 | -3,161 | -3,671 | -2,375 | -3,241 |
| Interest Expense | 161 | 50 | 95 | 94 | 86 |
| Other Income | 18 | 27 | 15 | 15 | 4 |
| Pre-tax Income | -5,158 | -3,185 | -3,751 | -2,453 | -3,323 |
| Income Tax | -11 | -2 | 5 | 3 | 2 |
| Net Income Continuous | -5,147 | -3,183 | -3,755 | -2,456 | -3,325 |
| Net Income | $-5,147 | $-3,183 | $-3,755 | $-2,456 | $-3,325 |
| EPS Basic Total Ops | -0.15 | -0.15 | -0.15 | -0.07 | -0.23 |
| EPS Basic Continuous Ops | -0.17 | -0.11 | -0.14 | -0.10 | -0.15 |
| EPS Diluted Total Ops | -0.15 | -0.15 | -0.15 | -0.07 | -0.23 |
| EPS Diluted Continuous Ops | -0.17 | -0.11 | -0.14 | -0.10 | -0.15 |
| EBITDA(a) | $-4,913 | $-3,055 | $-3,556 | $-2,268 | $-1,963 |